谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

TATEN TRIAL (SOLTI-1716) Targeting non-Luminal disease by PAM50 with pembrolizumab plus paclitaxel in Hormone Receptor-positive/HER2-negative (HR+/HER2-) metastatic breast cancer (MBC): interim analysis

Aleix Prat,Tomas Pascual,Montserrat Munoz,Cristina Hernando,Silvia Vazquez,Salvador Blanch,Manuel Alva,Mafalda Oliveira,Esther Sanfeliu,Lorea Villanueva,Fara Braso-Maristany,Nuria Chic,Eva Ciruelos

CANCER RESEARCH（2023）

引用 0|浏览39
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要